108 related articles for article (PubMed ID: 30614131)
1. Hepatitis C virus protein interaction network for HCV clearance and association of DAA to HCC occurrence via data mining approach: A systematic review and critical analysis.
Sghaier I; Brochot E; Loueslati BY; Almawi WY
Rev Med Virol; 2019 Mar; 29(2):e2033. PubMed ID: 30614131
[TBL] [Abstract][Full Text] [Related]
2. Host genetic variants influencing the clinical course of hepatitis C virus infection.
Matsuura K; Tanaka Y
J Med Virol; 2016 Feb; 88(2):185-95. PubMed ID: 26211651
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
4. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
[TBL] [Abstract][Full Text] [Related]
5. PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases.
De Re V; Tornesello ML; De Zorzi M; Caggiari L; Pezzuto F; Leone P; Racanelli V; Lauletta G; Zanussi S; Repetto O; Gragnani L; Rossi FM; Dolcetti R; Zignego AL; Buonaguro FM; Steffan A
Liver Int; 2021 Jan; 41(1):133-149. PubMed ID: 32937024
[TBL] [Abstract][Full Text] [Related]
6. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
Kato N; Ji G; Wang Y; Baba M; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Dharel N; Goto T; Shao RX; Matsuura T; Ishii K; Shiina S; Kawabe T; Muramatsu M; Omata M
Hepatology; 2005 Oct; 42(4):846-53. PubMed ID: 16175604
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection.
Wong MT; Chen SS
Cell Mol Immunol; 2016 Jan; 13(1):11-35. PubMed ID: 25544499
[TBL] [Abstract][Full Text] [Related]
8. Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Alkahtani S; Alarifi S; Alkahtane AA; Al-Yahya H; Ali D; Alessia MS; Alshahrani B; Al-Ahdal MN; Al-Qahtani AA
J Immunol Res; 2017; 2017():1590653. PubMed ID: 28127569
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of viral protein interaction networks in Hepatitis B virus and Hepatitis C virus infected HCC.
Yuan W; Huang T; Yu J; Zeng L; Lian B; He Q; Li Y; Zhang X; Zhou F; Xie L
Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):271-9. PubMed ID: 23774196
[TBL] [Abstract][Full Text] [Related]
10. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
11. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
[TBL] [Abstract][Full Text] [Related]
12. Diffusion of information throughout the host interactome reveals gene expression variations in network proximity to target proteins of hepatitis C virus.
Mosca E; Alfieri R; Milanesi L
PLoS One; 2014; 9(12):e113660. PubMed ID: 25461596
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients.
Sghaier I; Mouelhi L; Rabia NA; Alsaleh BR; Ghazoueni E; Almawi WY; Loueslati BY
Cytokine; 2017 Jan; 89():62-67. PubMed ID: 28340949
[TBL] [Abstract][Full Text] [Related]
14. Association of HCV mutated proteins and host SNPs in the development of hepatocellular carcinoma.
Suhail M; Sohrab SS; Qureshi A; Tarique M; Abdel-Hafiz H; Al-Ghamdi K; Qadri I
Infect Genet Evol; 2018 Jun; 60():160-172. PubMed ID: 29501636
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.
Yamashita T; Honda M; Kaneko S
J Gastroenterol Hepatol; 2011 Jun; 26(6):960-4. PubMed ID: 21443660
[TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of molecular mechanisms for HCC metastasis via text mining approach.
Zhen C; Zhu C; Chen H; Xiong Y; Tan J; Chen D; Li J
Oncotarget; 2017 Feb; 8(8):13909-13916. PubMed ID: 28108733
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and meta-analysis of HCV clearance.
Gauthiez E; Habfast-Robertson I; Rüeger S; Kutalik Z; Aubert V; Berg T; Cerny A; Gorgievski M; George J; Heim MH; Malinverni R; Moradpour D; Müllhaupt B; Negro F; Semela D; Semmo N; Villard J; Bibert S; Bochud PY;
Liver Int; 2017 Oct; 37(10):1431-1445. PubMed ID: 28261910
[TBL] [Abstract][Full Text] [Related]
18. TNF-α and IL-10 polymorphisms increase the risk to hepatocellular carcinoma in HCV infected individuals.
Aroucha DC; Carmo RF; Vasconcelos LR; Lima RE; Mendonça TF; Arnez LE; Cavalcanti Mdo S; Muniz MT; Aroucha ML; Siqueira ER; Pereira LB; Moura P; Pereira LM; Coêlho MR
J Med Virol; 2016 Sep; 88(9):1587-95. PubMed ID: 26890368
[TBL] [Abstract][Full Text] [Related]
19. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
[TBL] [Abstract][Full Text] [Related]
20. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
